Unique ID issued by UMIN | UMIN000008484 |
---|---|
Receipt number | R000009974 |
Scientific Title | a |
Date of disclosure of the study information | 2012/07/20 |
Last modified on | 2012/07/20 16:27:42 |
a
a
a
a
Japan |
Interstitial cystitis/ Hypersensitive bladder syndrome
Urology |
Others
NO
To assess the effect and safty of mirabegron on IC/ HBS patients.
Safety,Efficacy
Exploratory
Average voided volume at four weeks of the drug administration.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Administration of mirabegron 50mg per day for four weeks.
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients with IC/ HSB whose diagnose confirmed at our institution.
2. Patients
3. Patiens score VAS 3 points or more, and urinate 12times or more per day.
4. Patients who can be treated at outpatient clinic.
a
20
1st name | |
Middle name | |
Last name | Akira Nomiya |
University of Tokyo Hosital
Department of Urology
7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan.
03-5800-8753
1st name | |
Middle name | |
Last name | Akira Nomiya |
University of Tokyo
Department of Urology, Graduate school of medicine
7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan.
03-5800-8753
Department of Urology, Graduate school of medicine, University of Tokyo
Department of Urology, Graduate school of medicine, University of Tokyo
Self funding
NO
東京大学医学部附属病院
2012 | Year | 07 | Month | 20 | Day |
Unpublished
Preinitiation
2012 | Year | 06 | Month | 01 | Day |
2012 | Year | 07 | Month | 23 | Day |
2013 | Year | 03 | Month | 31 | Day |
2012 | Year | 07 | Month | 20 | Day |
2012 | Year | 07 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009974